SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-11-064130
Filing Date
2011-11-15
Accepted
2011-11-15 06:00:34
Documents
1
Period of Report
2011-11-14

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6415
  Complete submission text file 0001104659-11-064130.txt   7951
Mailing Address 33 PHAETON DRIVE MELVILLE NY 11747
Business Address
CERRONE GABRIEL (Reporting) CIK: 0001253803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 111205468

Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

IRS No.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations